These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 21193545)

  • 81. Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndrome.
    Bicer M; Alarslan P; Guler A; Demir I; Aslanipour B; Calan M
    J Endocrinol Invest; 2020 Mar; 43(3):305-313. PubMed ID: 31486991
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats.
    Yang Z; Shi J; Guo Z; Chen M; Wang C; He C; Zuo Z
    Chemosphere; 2019 Sep; 231():151-160. PubMed ID: 31129395
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Serum testosterone predicts cardiorespiratory fitness impairment in normal-weight women with polycystic ovary syndrome.
    Bacchi E; Negri C; Di Sarra D; Tosi F; Tarperi C; Moretta R; Schena F; Bonora E; Kaufman JM; Moghetti P
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):895-901. PubMed ID: 26173542
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?
    Al Nofal A; Viers LD; Javed A
    Gynecol Endocrinol; 2017 Nov; 33(11):882-887. PubMed ID: 28649885
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women.
    Medeiros SF; Barbosa JS; Yamamoto MM
    J Obstet Gynaecol Res; 2015 Feb; 41(2):254-63. PubMed ID: 25256274
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Increased levels of bisphenol A (BPA) in Thai girls with precocious puberty.
    Supornsilchai V; Jantarat C; Nosoognoen W; Pornkunwilai S; Wacharasindhu S; Soder O
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1233-1239. PubMed ID: 26812862
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bisphenol A and cardiometabolic risk factors in obese children.
    Khalil N; Ebert JR; Wang L; Belcher S; Lee M; Czerwinski SA; Kannan K
    Sci Total Environ; 2014 Feb; 470-471():726-32. PubMed ID: 24184549
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Daily intake of bisphenol A and triclosan and their association with anthropometric data, thyroid hormones and weight loss in overweight and obese individuals.
    Geens T; Dirtu AC; Dirinck E; Malarvannan G; Van Gaal L; Jorens PG; Covaci A
    Environ Int; 2015 Mar; 76():98-105. PubMed ID: 25575039
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study.
    Jin C; Zou K; Xu Y; Yang H; Pan J
    BMC Endocr Disord; 2021 Dec; 21(1):240. PubMed ID: 34856980
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effect of prolactin levels on MPV in women with PCOS.
    Yilmaz Ö; Calan M; Kume T; Temur M; Yesil P; Senses MY
    Clin Endocrinol (Oxf); 2015 May; 82(5):747-52. PubMed ID: 25359296
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.
    Kume T; Calan M; Yilmaz O; Kocabas GU; Yesil P; Temur M; Bicer M; Calan OG
    J Endocrinol Invest; 2016 Jul; 39(7):747-54. PubMed ID: 26969461
    [TBL] [Abstract][Full Text] [Related]  

  • 92. There is no difference in the plasma cortisol level between women with body mass index (BMI) greater than or equal 25 kg/m² and polycystic ovary syndrome and the control group without polycystic ovary syndrome and BMI 25 kg/m².
    Mrozińska S; Milewicz T; Kiałka M; Gosztyła K; Lurzyńska M; Kabzińska-Turek M
    Przegl Lek; 2016; 73(4):207-9. PubMed ID: 27526420
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fatty liver index in polycystic ovary syndrome.
    Lerchbaum E; Gruber HJ; Schwetz V; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 Dec; 165(6):935-43. PubMed ID: 21937505
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome.
    Vigorito C; Giallauria F; Palomba S; Cascella T; Manguso F; Lucci R; De Lorenzo A; Tafuri D; Lombardi G; Colao A; Orio F
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1379-84. PubMed ID: 17264174
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome.
    Tosi F; Fiers T; Kaufman JM; Dall'Alda M; Moretta R; Giagulli VA; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2016 Feb; 101(2):610-8. PubMed ID: 26695861
    [TBL] [Abstract][Full Text] [Related]  

  • 96. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus.
    Amato MC; Guarnotta V; Ciresi A; Modica R; Pantò F; Giordano C
    J Clin Endocrinol Metab; 2014 Jan; 99(1):203-11. PubMed ID: 24243639
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Increased Coagulation and Decreased Fibrinolysis as Measured with Overall Hemostatic Potential Are Dependent on BMI and Not Associated with PCOS.
    Rakusa M; Jensterle M; Božič-Mijovski M; Janez A
    Metab Syndr Relat Disord; 2017 May; 15(4):194-198. PubMed ID: 28287900
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Bisphenol A and Ovarian Reserve among Infertile Women with Polycystic Ovarian Syndrome.
    Zhou W; Fang F; Zhu W; Chen ZJ; Du Y; Zhang J
    Int J Environ Res Public Health; 2016 Dec; 14(1):. PubMed ID: 28036005
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome.
    Ozler S; Oztas E; Tokmak A; Ergin M; Isci E; Eren F; Pehlivan S; Neselioglu S; Yılmaz N
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):516-23. PubMed ID: 26492953
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Eur J Endocrinol; 2014 May; 170(5):727-39. PubMed ID: 24591551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.